<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-11-28</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604383/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Remodelling of Rea1 linker domain drives the removal of assembly factors from pre-ribosomal particles</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604383-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The ribosome maturation factor Rea1 (or Midasin) catalyses the removal of assembly factors from large ribosomal subunit precursors and promotes their export from the nucleus to the cytosol. Rea1 consists of nearly 5000 amino-acid residues and belongs to the AAA+ protein family. It consists of a ring of six AAA+ domains from which the â‰ˆ1700 amino-acid residue linker emerges that is subdivided into stem, middle and top domains. A flexible and unstructured D/E rich region connects the linker top &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604394/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Multi-biome analysis identifies distinct gut microbial signatures and their crosstalk in ulcerative colitis and Crohn&#39;s disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604394-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The integrative multi-kingdom interaction of the gut microbiome in ulcerative colitis (UC) and Crohn&rsquo;s disease (CD) remains underinvestigated. Here, we perform shotgun metagenomic sequencing of feces from patients with UC and CD, and healthy controls in the Japanese 4D cohort, profiling bacterial taxa, gene functions, and antibacterial genes, bacteriophages, and fungi. External metagenomic datasets from the US, Spain, the Netherlands, and China were analyzed to validate our multi-biome &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604428/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Longitudinal markers of cognitive procedural learning in fronto-striatal circuits and putative effects of a BDNF plasticity-related variant</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604428-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Procedural learning and automatization have widely been studied in behavioral psychology and typically involves a rapid improvement, followed by a plateau in performance throughout repeated training. More recently, brain imaging studies have implicated frontal-striatal brain circuits in skill learning. However, it is largely unknown whether frontal-striatal activation during skill learning and behavioral changes follow a similar learning curve pattern. To address this gap in knowledge, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604430/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">LungVis 1.0: an automatic AI-powered 3D imaging ecosystem unveils spatial profiling of nanoparticle delivery and acinar migration of lung macrophages</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604430-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Targeted (nano-)drug delivery is essential for treating respiratory diseases, which are often confined to distinct lung regions. However, spatio-temporal profiling of drugs or nanoparticles (NPs) and their interactions with lung macrophages remains unresolved. Here, we present LungVis 1.0, an AI-powered imaging ecosystem that integrates light sheet fluorescence microscopy with deep learning-based image analysis pipelines to map NP deposition and dosage holistically and quantitatively &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604531/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Comparing epidemiological and clinical data from RPS patients documented in a German cancer registry to a cohort from TARPSWG reference centres</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604531-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: ICD-O/ICD 10 based filters appear to be a valid tool for extracting RPS cases from CR. The similar distribution and biological behavior of distinct RPS subtypes suggests that TARPS-WG are representative, and CR data may be used to verify recommendations derived from reference centre cohorts. Complementary use of data from different sources warrants further investigation in rare &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604549/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">The path forward for large language models in medicine is open</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604549-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings reveal a significant association between spleen signal intensity especially on normalized T2-weighted images and tumor &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39604696/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Microvascular Plug Embolization of Anterior Spinal Artery Bearing Segmental Arteries Prior Aortic Stenting: Technique and Safety</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39604696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: MVP deployment into the ASAbSA is a safe strategy for protecting the spinal cord during preemptive embolization of segmental arteries prior to endovascular aortic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39605093/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Protocol for a systematic review with meta-analysis and trial sequential analysis of preventive interventions versus any control intervention for parents with a mental disorder on offspring outcomes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39605093-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Offspring of parents with a mental disorder are at high risk of a range of adverse outcomes, highlighting the need for preventive interventions. However, a comprehensive overview of the beneficial and harmful effects of preventive interventions for parents with mental disorders on offspring outcomes are uncertain. The main objective of this systematic review will be to assess the effects of preventive interventions versus any control intervention for parents with a mental disorder &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39605194/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Methotrexate Versus Mycophenolate Mofetil Prophylaxis inÂ Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39605194-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Prophylaxis strategies for Graft versus host disease (GVHD) in allogeneic hematopoietic cell transplantation (allo-HCT) frequently encompass a combination of a calcineurin inhibitor (CNI) with either methotrexate (MTX) or mycophenolate mofetil (MMF). The aim of this retrospective, EBMT registry-based study was to determine outcome differences for chronic myeloid malignancies and secondary acute myeloid leukemia (sAML) between MTX- and MMF-based prophylaxis regimens while taking &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39606231/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Impact of induction agents and maintenance immunosuppression on torque teno virus loads and year-one complications after kidney transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39606231-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Higher TTVL reflects the greater immunosuppressive burden in immunological high-risk patients receiving intensive immunosuppression. The choice of induction agent and intensified immunosuppressive maintenance therapy notably affects TTVL at 3 months post-transplant and beyond, necessitating careful consideration when interpreting and applying TTVL cutoffs to monitor immunocompetence &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39606627/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Automated lung segmentation on chest MRI in children with cystic fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39606627-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Segmentation of lung structures in medical imaging is crucial for the application of automated post-processing steps on lung diseases like cystic fibrosis (CF). Recently, machine learning methods, particularly neural networks, have demonstrated remarkable improvements, often outperforming conventional segmentation methods. Nonetheless, challenges still remain when attempting to segment various imaging modalities and diseases, especially when the visual characteristics of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39606715/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20241128174903&amp;v=2.18.0.post9&#43;e462414">Mixed Effects Deep Learning for the interpretable analysis of single cell RNA sequencing data by quantifying and visualizing batch effects</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39606715-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20241128174903-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Single-cell RNA sequencing (scRNA-seq) data are often confounded by technical or biological batch effects. Existing deep learning models mitigate these effects but often discard batch-specific information, potentially losing valuable biological insights. We propose a Mixed Effects Deep Learning (MEDL) autoencoder framework that separately models batch-invariant (fixed effects) and batch-specific (random effects) components. By decoupling batch-invariant biological states from batch &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39606939/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Resistance training for fatigue in people with cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39606939-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Cancer-related fatigue (CRF) is one of the most common symptoms associated with cancer and its treatment. Different types of exercise have demonstrated beneficial effects on CRF. Previous evidence syntheses provided promising but inconclusive results when focusing on the effects of resistance &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607015/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Critical Evaluation of Childs Method for the NMR Spectroscopic Scaling of Effective Lewis Acidity: Limitations and Resolution of Earlier Discrepancies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607015-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Quantifying Lewis acidity is essential for understanding and optimizing the performance of Lewis acids in diverse applications. Next to the widely accepted Gutmann-Beckett (GB) method, using triethyl phosphine oxide (TEPO) as a probe, the Childs method-employing trans-crotonaldehyde (TCA)-gained attention as an NMR-based technique for measuring effective Lewis acidity (eLA). Despite its steady use, the robustness of Childs method and its correlation with other measures remain &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607018/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Early-life challenge enhances cortisol regulation in zebrafish larvae</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607018-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The hypothalamic-pituitary-adrenal (HPA) axis in mammals and the hypothalamic-pituitary-interrenal (HPI) axis in fish are open systems that adapt to the environment during development. Little is known about how this adaptation begins and regulates early stress responses. We used larval zebrafish to examine the impact of prolonged forced swimming at 5 days post-fertilization (dpf), termed early-life challenge (ELC), on cortisol responses, neuropeptide expression in the nucleus preopticus &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607361/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Basic and preclinical epilepsy research Scientists&#39; perception of clinical epileptology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607361-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The interaction between basic science epilepsy researchers and clinical epileptologists is a longstanding issue. Efforts to provide opportunities for a dialogue between preclinical and clinical epilepsy professionals are crucial to reduce the knowledge gap between them and improve the translational success of neurobiology-based research. The International League Against Epilepsy (ILAE) Research and Innovation Task Force circulated a survey to investigate the need for an update on new &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607461/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Summary of the S1 guideline on sustainability in intensive care and emergency medicine</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607461-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The guideline shows that there are already relevant and concrete possibilities for more sustainable work in intensive care and emergency medicine. However, there is a need for further research (e.g., detailed analyses, such as life cycle assessment) on how exactly to reduce the environmental impact of medical facilities, while maintaining high-quality patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607474/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607474-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The pooled analysis confirmed that the water-free ciclosporin 0.1% solution is effective in improving ocular surface staining after 2 weeks of treatment to a clinically relevant extent in more than 50% of patients in the overall population and subgroups. With an early onset and good tolerability, the product has the potential to address an unmet medical need in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607518/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Microsurgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607518-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607578/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241128174912&amp;v=2.18.0.post9&#43;e462414">Correction: Mitochondrial respiratory pathways in immature rat heart tissue using different cardioplegic solutions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607578-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241128174912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607711/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241128173846&amp;v=2.18.0.post9&#43;e462414">Bone marrow Gaucheromas</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607711-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241128173846-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607712/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241128173846&amp;v=2.18.0.post9&#43;e462414">Can JAK inhibition prevent GVHD?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607712-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241128173846-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607713/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241128173846&amp;v=2.18.0.post9&#43;e462414">Time to address bleeding and clotting in cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607713-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241128173846-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607714/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241128173846&amp;v=2.18.0.post9&#43;e462414">HLH: diagnostics revisited and improved</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607714-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241128173846-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607715/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241128173846&amp;v=2.18.0.post9&#43;e462414">Staying in the loop blocks oncogene activation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607715-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241128173846-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39607716/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241128173846&amp;v=2.18.0.post9&#43;e462414">INCA033989: the first shot on goal for MPNs?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39607716-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241128173846-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs), inhibiting its oncogenic activity without affecting normal &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2n9m3Tcm">å—å¡åŒ»å­¦é™¢åœ¨JAMAä¸Šå‘è¡¨äº†ååˆ†é‡è¦çš„èŸèƒåˆ†æï¼Œåˆ†æäº†1992-2021å¹´30å¹´æ¥HPVç–«è‹—æ¥ç§å¯¹å¥³æ€§å¥åº·çš„å½±å“ã€‚HPVç–«è‹—æ˜¯äººç±»é¦–ä¸ªç”¨äºé¢„é˜²æ¶æ€§è‚¿ç˜¤çš„ç–«è‹—ï¼ˆé¢„é˜²HPVå¼•å‘çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2n9m3tcm/">
    
    
    
    
    
      
    
    å—å¡åŒ»å­¦é™¢åœ¨JAMAä¸Šå‘è¡¨äº†ååˆ†é‡è¦çš„èŸèƒåˆ†æï¼Œåˆ†æäº†1992-2021å¹´30å¹´æ¥HPVç–«è‹—æ¥ç§å¯¹å¥³æ€§å¥åº·çš„å½±å“ã€‚HPVç–«è‹—æ˜¯äººç±»é¦–ä¸ªç”¨äºé¢„é˜²æ¶æ€§è‚¿ç˜¤çš„ç–«è‹—ï¼ˆé¢„é˜²HPVå¼•å‘çš„å®«é¢ˆç™Œç­‰ï¼‰ã€‚è¿™é¡¹ç ”ç©¶å‘ç°HPVç–«è‹—æ¥ç§æ™®åŠçš„2019-2021å¹´ç›¸æ¯”2013-2015å¹´ï¼Œæ¯å¹´å®«é¢ˆç™Œæ­»äº¡ä¸‹é™15.2%ã€‚è¿™å……åˆ†æ˜¾ç¤ºäº†HPVç–«è‹—æ¥ç§çš„æ˜¾è‘—æ„ä¹‰ã€‚ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2q9RtO0n">CA-13å’ŒCA-45ç¿»è“ï¼Œæœ€ç»ˆä¼—è®®é™¢R: Dä¸º220: 215å¸­ï¼Œè€ƒè™‘åˆ°Stefanikå°†å‡ºä»»è”åˆå›½å¤§ä½¿ï¼Œè€ŒGaetzè¾èŒï¼Œç›®å‰ä¸º217: 215å¸­ï¼Œè¿™æ˜¯å†å²ä¸Šä¸¤å…šæœ€æ¥è¿‘çš„ä¼—è®®é™¢ç»„æˆï¼Œä»Šåä¸¤...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2q9rto0n/">
    
    
    
    
    
      
    
    CA-13å’ŒCA-45ç¿»è“ï¼Œæœ€ç»ˆä¼—è®®é™¢R: Dä¸º220: 215å¸­ï¼Œè€ƒè™‘åˆ°Stefanikå°†å‡ºä»»è”åˆå›½å¤§ä½¿ï¼Œè€ŒGaetzè¾èŒï¼Œç›®å‰ä¸º217: 215å¸­ï¼Œè¿™æ˜¯å†å²ä¸Šä¸¤å…šæœ€æ¥è¿‘çš„ä¼—è®®é™¢ç»„æˆï¼Œä»Šåä¸¤å¹´å°†å¾ˆéš¾ç«‹æ³•ã€‚ä»Šå¹´Dèµ¢å›äº†ä¸¤å¸­ä¼—è®®é™¢å¸­ä½ï¼Œè¿™è¯´æ˜Houseç«é€‰å¾ˆæˆåŠŸã€‚ç›®å‰æ€»ç»Ÿå¤§é€‰çš„ç¥¨æ•°ä¾ç„¶åœ¨ç»Ÿè®¡ï¼Œå·®è·å·²ç»ç¼©å°åˆ°1.55%ï¼Œæ¥è¿‘å¤§é€‰å‰é¢„æµ‹çš„dead heatï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_d">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_d</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2rNYzS9P">Duke - DHVIçš„Williamsç»„åœ¨Nature Communicationså‘è¡¨äº†ä¸€é¡¹HIVç ”ç©¶ï¼ŒæŠ¥é“äº†å¹¼å¹´æ’æ²³çŒ´å¯¹HIVï¼ˆSHIVï¼‰æŠ—ä½“å…ç–«åº”ç­”ä¸æˆå¹´æ’æ²³çŒ´çš„ä¸åŒã€‚ç ”ç©¶æ¯”è¾ƒäº†11åªæ–°ç”Ÿæ’æ²³çŒ´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2rnyzs9p/">
    
    
    
    
    
      
    
    Duke - DHVIçš„Williamsç»„åœ¨Nature Communicationså‘è¡¨äº†ä¸€é¡¹HIVç ”ç©¶ï¼ŒæŠ¥é“äº†å¹¼å¹´æ’æ²³çŒ´å¯¹HIVï¼ˆSHIVï¼‰æŠ—ä½“å…ç–«åº”ç­”ä¸æˆå¹´æ’æ²³çŒ´çš„ä¸åŒã€‚ç ”ç©¶æ¯”è¾ƒäº†11åªæ–°ç”Ÿæ’æ²³çŒ´å’Œ11åªæˆå¹´æ’æ²³çŒ´åœ¨æ„ŸæŸ“SHIVå24ä¸ªæœˆä¹‹å†…çš„æŠ—ä½“å…ç–«åº”ç­”ï¼Œå‘ç°64%æ–°ç”Ÿæ’æ²³çŒ´å’Œ18%æˆå¹´æ’æ²³çŒ´äº§ç”Ÿäº†å¤šå…ƒåŒ–çš„å¼‚æºä¸­å’ŒæŠ—ä½“ã€‚å¹¼å¹´æ’æ²³çŒ´æ„ŸæŸ“å12ä¸ªæœˆå‡ºç°å¼‚æºHIV-1ä¸­å’ŒæŠ—ä½“ï¼ŒåŒæ—¶ä¼´æœ‰å…ç–«æŠ‘åˆ¶åŸºå› è¡¨è¾¾ä¸‹è°ƒã€ç”Ÿå‘ä¸­å¿ƒGC Tregä»¥åŠæ»¤æ³¡Tregä¸Tfh CD4 Tç»†èƒæ¯”å€¼é™ä½ã€‚æ„ŸæŸ“SHIVåï¼Œä¸¤åªå¹¼å¹´æ’æ²³çŒ´çš„å¤–å‘¨è¡€Bç»†èƒäº§ç”Ÿçš„æŠ—ä½“å¯ä¸­å’Œ119ç§å¼‚æºHIV-1æ¯’æ ªä¸­13%ï¼›ç ”ç©¶å¹¶å®šä½åˆ°HIV-1è†œè›‹ç™½Envä¸Šçš„å…¸å‹å¹¿è°±ä¸­å’ŒæŠ—ä½“ï¼ˆbNAbsï¼‰è¡¨ä½åŒºåŸŸã€‚è¿™ä¸€ç»“æœæ˜¾ç¤ºäº†æ–°ç”Ÿæ’æ²³çŒ´å’Œæˆå¹´æ’æ²³çŒ´å…·æœ‰ä¸åŒçš„HIV-1ä½“æ¶²å…ç–«åº”ç­”ï¼Œä»è€Œæç¤ºäº†åœ¨ä¸åŒå¹´é¾„æ®µè¯±å¯¼å¹¿è°±ä¸­å’ŒæŠ—ä½“åº”ç­”å¯ä»¥åº”ç”¨ä¸åŒå…ç–« &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/P2pVffEVd">è¥¿æ¸¸èŠ‚ç›®ä¸Šçº¿å•¦ğŸˆè¯¦æƒ…è§è¯„ğŸ’ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-p2pvffevd/">
    
    
    
    
    
      
    
    è¥¿æ¸¸èŠ‚ç›®ä¸Šçº¿å•¦ğŸˆè¯¦æƒ…è§è¯„ğŸ’ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2s5h7AeG">ğŸ”»å“ªæ€•è£…ä¸€ä¸‹å•Šå“ˆå“ˆå§ã€‚ğŸ”»ä½ è¿™æ ·å¥½åƒè´¥çŠ¬å•Šã€‚ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2s5h7aeg/">
    
    
    
    
    
      
    
    ğŸ”»å“ªæ€•è£…ä¸€ä¸‹å•Šå“ˆå“ˆå§ã€‚<!-- raw HTML omitted -->ğŸ”»ä½ è¿™æ ·å¥½åƒè´¥çŠ¬å•Šã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2s7CdQc0">ğŸ”»æˆ‘ä¸€æœ‹å‹ä»Šæ™šç»™æˆ‘è¯´å¥¹çœ‹è¿™èŠ‚ç›®æ°”å“­äº†ã€‚ğŸ”»æˆ‘ï¼š[å“†å•¦Aæ¢¦åƒæƒŠ]#æ²™ä¸€æ±€éº¦ç³# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2s7cdqc0/">
    
    
    
    
    
      
    
    ğŸ”»æˆ‘ä¸€æœ‹å‹ä»Šæ™šç»™æˆ‘è¯´å¥¹çœ‹è¿™èŠ‚ç›®æ°”å“­äº†ã€‚<!-- raw HTML omitted -->ğŸ”»æˆ‘ï¼š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ²™ä¸€æ±€éº¦ç³#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hw2flvbz9sg209208w7wt.gif%22">https://tvax2.sinaimg.cn/large/639b1bfbly1hw2flvbz9sg209208w7wt.gif&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2sbVxnOr">ğŸ”»å‘µ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2sbvxnor/">
    
    
    
    
    
      
    
    ğŸ”»å‘µ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2scdjsUR">ç¬¬ä¸€å¼ ä¸æ˜¯é»„æ¸¤å—ï¼Ÿ - è½¬å‘ @é›©æ­Œ_:&amp;ensp;åˆ«çš„ä¸è¯´å•Šï¼Œè¿™å‰§çœŸçš„æ˜¯èƒ½é æ½˜ç²¤æ˜ä¸€å·±ä¹‹åŠ›æ’‘èµ·æ¥ã€‚ã€‚ã€‚ä»–éƒ½ä¸ç”¨å°è¯ï¼Œå…‰é é¢éƒ¨å¾®è¡¨æƒ…çš„è°ƒèŠ‚å°±å¯ä»¥è®©è§‚ä¼—åŒºåˆ†å‡ºä¸¤ä¸ªæ€§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2scdjsur/">
    
    
    
    
    
      
    
    ç¬¬ä¸€å¼ ä¸æ˜¯é»„æ¸¤å—ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é›©æ­Œ_<!-- raw HTML omitted -->:â€‚åˆ«çš„ä¸è¯´å•Šï¼Œè¿™å‰§çœŸçš„æ˜¯èƒ½é æ½˜ç²¤æ˜ä¸€å·±ä¹‹åŠ›æ’‘èµ·æ¥ã€‚ã€‚ã€‚<!-- raw HTML omitted -->ä»–éƒ½ä¸ç”¨å°è¯ï¼Œå…‰é é¢éƒ¨å¾®è¡¨æƒ…çš„è°ƒèŠ‚å°±å¯ä»¥è®©è§‚ä¼—åŒºåˆ†å‡ºä¸¤ä¸ªæ€§æ ¼è¿¥å¼‚çš„äººæ ¼ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç™½å¤œç ´æ™“#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2sfla6I6">ğŸ”»æŠ›å¼€å¢å¸ƒè¢«è¸¢å‡ºswiftã€ä¿„å›½äººç°åœ¨æ ¹æœ¬ä¸ç”¨å¢å¸ƒå…‘ç¾å…ƒä¸è®ºï¼Œè¿™ä¸‰å¼ å›¾çœ‹èµ·æ¥ï¼Œå“ªå¼ æ›´åƒâ€œå´©äº†â€ï¼Ÿ#å¢å¸ƒå´©äº†# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2sfla6i6/">
    
    
    
    
    
      
    
    ğŸ”»æŠ›å¼€å¢å¸ƒè¢«è¸¢å‡ºswiftã€ä¿„å›½äººç°åœ¨æ ¹æœ¬ä¸ç”¨å¢å¸ƒå…‘ç¾å…ƒä¸è®ºï¼Œè¿™ä¸‰å¼ å›¾çœ‹èµ·æ¥ï¼Œå“ªå¼ æ›´åƒâ€œå´©äº†â€ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å¢å¸ƒå´©äº†#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hw2g1b9ahxj20u20iv0y6.jpg%22">https://tvax2.sinaimg.cn/large/639b1bfbly1hw2g1b9ahxj20u20iv0y6.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2sgKnx7V">ğŸ”»Ğ Ğ‘Ğšï¼šæ™®äº¬ç¦»å¼€é˜¿æ–¯å¡”çº³å›å›½ã€‚#ç¾å›½å¯¹ä¿„ä¹Œå†²çªç«‹åœºå‘ç”Ÿé‡å¤§è½¬å˜# åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2sgknx7v/">
    
    
    
    
    
      
    
    ğŸ”»Ğ Ğ‘Ğšï¼šæ™®äº¬ç¦»å¼€é˜¿æ–¯å¡”çº³å›å›½ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç¾å›½å¯¹ä¿„ä¹Œå†²çªç«‹åœºå‘ç”Ÿé‡å¤§è½¬å˜#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2shdCDZj">ğŸ”»ä»¥å†›å’Œé»å·´å«©å†›é˜Ÿå‡ç¡®è®¤ä»¥å†›è¿ååœç«åè®®ã€‚ğŸ”»via ajanews æ–°é—»ç½‘#é»ä»¥åœç«åè®®ä»Šæ—¥10æ—¶ç”Ÿæ•ˆ# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2shdcdzj/">
    
    
    
    
    
      
    
    ğŸ”»ä»¥å†›å’Œé»å·´å«©å†›é˜Ÿå‡ç¡®è®¤ä»¥å†›è¿ååœç«åè®®ã€‚<!-- raw HTML omitted -->ğŸ”»via ajanews æ–°é—»ç½‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»ä»¥åœç«åè®®ä»Šæ—¥10æ—¶ç”Ÿæ•ˆ#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg">https://tvax1.sinaimg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2sj2knGy">ä¸å¤ªä¸€æ ·ï¼Œå°Šé‡ä¸€ä¸‹æ”¯æ•™çš„åŸä¸»æ’­æœ¬äººï¼Œæˆ‘è®°å¾—å¥¹å…¬å¼€è¡¨è¾¾è¿‡å¯¹ç±»ä¼¼è¯´æ³•çš„åæ„Ÿã€‚//@F_Nameless__:å±±æ‘å¥³æ•™ä¸‹ç­è·³èˆä¸ºå±±åŒºå­©å­[ç¬‘è€Œä¸è¯­] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;e...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2sj2kngy/">
    
    
    
    
    
      
    
    ä¸å¤ªä¸€æ ·ï¼Œå°Šé‡ä¸€ä¸‹æ”¯æ•™çš„åŸä¸»æ’­æœ¬äººï¼Œæˆ‘è®°å¾—å¥¹å…¬å¼€è¡¨è¾¾è¿‡å¯¹ç±»ä¼¼è¯´æ³•çš„åæ„Ÿã€‚//<!-- raw HTML omitted -->@F_Nameless__<!-- raw HTML omitted -->:å±±æ‘å¥³æ•™ä¸‹ç­è·³èˆä¸ºå±±åŒºå­©å­<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»è‡ªå§‹è‡³ç»ˆæˆ‘å¯¹å´æŸ³èŠ³æœ¬äººéƒ½æ²¡æœ‰ä»€ä¹ˆæ‰¹è¯„ã€‚åªæ˜¯æ¨å¥¹çš„æœºæ„é€‰æ‹©äº†ä¸å±äºä»–ä»¬çš„æµé‡ï¼Œè¿™éƒ¨åˆ†æµé‡è¢«ææ‰äº†ã€‚<!-- raw HTML omitted -->ğŸ”»é‚£äº›åœ¨å´æŸ³èŠ³é»˜é»˜æ— é—»åšå…¬ç›Šã€å‘è·³èˆè§†é¢‘æ—¶æ— åŠ¨äºè¡·ï¼Œåœ¨å¥¹é€‰æ‹©è¿™ç§æ–¹å¼å¼€å·æ—¶æ‰å¼€å§‹ç™«ç‹‚çš„çœ‹å®¢ï¼Œæ¯”é€‰æ‰‹æœ¬äººå¯æ¶å¤šäº†ã€‚<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2sqD98kz">ğŸ”»é»å·´å«©æ€»ç†çº³å‰å¸ƒÂ·ç±³å¡æå‘¼åå‘ä»¥è‰²åˆ—æ–½åŠ å‹åŠ›ï¼Œâ€œé˜»æ­¢å…¶è¿ååœç«åè®®ï¼Œä»Šå¤©è¿ååœç«åè®®é€ æˆäº†äººå‘˜ä¼¤äº¡å’Œå¤§è§„æ¨¡ç‰©è´¨æŸå¤±â€ã€‚ğŸ”»ä»¥è‰²åˆ—æ€»ç†å†…å¡”å°¼äºšèƒ¡åˆ™è¡¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2sqd98kz/">
    
    
    
    
    
      
    
    ğŸ”»é»å·´å«©æ€»ç†çº³å‰å¸ƒÂ·ç±³å¡æå‘¼åå‘ä»¥è‰²åˆ—æ–½åŠ å‹åŠ›ï¼Œâ€œé˜»æ­¢å…¶è¿ååœç«åè®®ï¼Œä»Šå¤©è¿ååœç«åè®®é€ æˆäº†äººå‘˜ä¼¤äº¡å’Œå¤§è§„æ¨¡ç‰©è´¨æŸå¤±â€ã€‚<!-- raw HTML omitted -->ğŸ”»ä»¥è‰²åˆ—æ€»ç†å†…å¡”å°¼äºšèƒ¡åˆ™è¡¨ç¤ºï¼šâ€œæˆ‘æŒ‡ç¤ºå†›é˜Ÿåšå¥½å‡†å¤‡ï¼Œä¸€æ—¦å‘ç”Ÿä»»ä½•è¿ååœç«åè®®çš„æƒ…å†µï¼Œå°±ä¼šåœ¨é»å·´å«©å‘åŠ¨ä¸€åœºçŒ›çƒˆçš„æˆ˜äº‰ã€‚ç”±äºæˆ‘ä»¬æ‹†é™¤äº†åœ°ä¸Šå’Œåœ°ä¸‹çš„å†›äº‹å»ºç­‘ï¼ŒçœŸä¸»å…šä»é™†è·¯æ¸—é€åˆ°ä»¥è‰²åˆ—åŒ—éƒ¨çš„å±é™©å·²ç»æ¶ˆå¤±ã€‚â€<!-- raw HTML omitted -->ğŸ”»ä»¥å†›åœ¨åŒ—æ–¹åªå‰©ä¸€ä¸ªæ—…èƒ½åŠ¨äº†ï¼Œé‡æ–°åœ¨é™†åœ°ä¸Šå‘èµ·å¤§è§„æ¨¡è¿›æ”»æ˜¯æ‰“ä¸èµ·æ¥çš„ã€‚ä¸»è¦è¿˜æ˜¯é ç©ºè¢­ã€‚<!-- raw HTML omitted -->ğŸ”»6æœˆä»½æˆ‘çŒœä»¥å†›çš„åŒ—ä¼å¿…é¡»åœ¨50-65å¤©å†…å®Œæˆæˆ˜å½¹ç›®æ ‡å¹¶æ’¤é€€ï¼Œå› ä¸ºè‡ªåŠ æ²™å†²çªçˆ†å‘ä»¥æ¥ï¼Œæ²¡æœ‰ä¸€ä¸ªä»¥è‰²åˆ—é¢„å¤‡å½¹æ—…åœ¨åŠ æ²™çš„æˆ˜æ–—èƒ½å¤Ÿç»´æŒ65å¤©ä»¥ä¸Šâ€”â€”ç„¶åå®ƒä»¬å°±è§£æ•£äº†ã€‚<!-- raw HTML omitted -->ğŸ”»ç»“æœä»¥å†›è¿™è½®åŒ—ä¼çš„åœ°é¢æˆ˜æ–—åªåšæŒäº†57å¤©ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E4%BB%A5%E5%81%9C%E7%81%AB%E5%8D%8F%E8%25A">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%8E%E4%BB%A5%E5%81%9C%E7%81%AB%E5%8D%8F%E8%A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P2suihwZN">ğŸ”»ä»¥è‰²åˆ—å›½é˜²å†›å®˜æ–¹è´¦å·å®£ç§°ç¦æ­¢é»å·´å«©äººå›åˆ°é»å·´å«©å—éƒ¨ä»¥ä¸‹åœ°åŒºã€‚#é»ä»¥åœç«åè®®ä»Šæ—¥10æ—¶ç”Ÿæ•ˆ# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p2suihwzn/">
    
    
    
    
    
      
    
    ğŸ”»ä»¥è‰²åˆ—å›½é˜²å†›å®˜æ–¹è´¦å·å®£ç§°ç¦æ­¢é»å·´å«©äººå›åˆ°é»å·´å«©å—éƒ¨ä»¥ä¸‹åœ°åŒºã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»ä»¥åœç«åè®®ä»Šæ—¥10æ—¶ç”Ÿæ•ˆ#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P2nJB0iZD">æ—¶éš”ä¸çŸ¥é“å¤šå°‘å¤©ä¸­äº† [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p2njb0izd/">
    
    
    
    
    
      
    
    æ—¶éš”ä¸çŸ¥é“å¤šå°‘å¤©ä¸­äº† <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P2o9P3DKv">å½“å¹´è¢«äº•å±±0-10çš„ä¸€åŠ›è¾½ï¼Œä¹Ÿæ²¡æœ‰åƒä»Šå¹´è™ä¸¸é‚£æ ·å…¨å¹´å¤´è¡”æˆ˜é«˜åº¦å‚ä¸ç„¶åä¸ƒå¤§çš†ç©ºçš„#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p2o9p3dkv/">
    
    
    
    
    
      
    
    å½“å¹´è¢«äº•å±±0-10çš„ä¸€åŠ›è¾½ï¼Œä¹Ÿæ²¡æœ‰åƒä»Šå¹´è™ä¸¸é‚£æ ·å…¨å¹´å¤´è¡”æˆ˜é«˜åº¦å‚ä¸ç„¶åä¸ƒå¤§çš†ç©ºçš„<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P2ohtC6C1">å“ˆï¼Ÿï¼Ÿï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p2ohtc6c1/">
    
    
    
    
    
      
    
    å“ˆï¼Ÿï¼Ÿï¼Ÿ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P2qk9DX88">ä¸Šé‡ä¸‹ä¸äº†äº†å•Šå–‚å®˜æ–¹å¹²ç‚¹æ´» [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p2qk9dx88/">
    
    
    
    
    
      
    
    ä¸Šé‡ä¸‹ä¸äº†äº†å•Šå–‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å®˜æ–¹å¹²ç‚¹æ´» <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2nxErHDs">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬ï½ä»Šæ™šè¦å…¬å¸ƒé’æ˜¥æ–‡åŒ–ç¥­çš„å‘¨è¾¹å“Ÿï¼ï¼ï¼ï¼è¶…çº§å¯çˆ±çš„ã€‚ã€‚ã€‚è¶…çº§å¯çˆ±ã€‚ã€‚ã€‚ [å›¾ç‰‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2nxerhds/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigra &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2ogOzVSG">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.11.28 15:19ã€Œæ¬¸å˜¿å˜¿ã€æ—©ä¸Šå¥½å“‡ã€œä»Šå¤©ä¹Ÿåœ¨å·¥ä½œä»Šå¤©è·Ÿå¯çˆ±çš„åè¾ˆä¸€èµ·å·¥ä½œè¶…å¯çˆ±ã€‚è¶…å–œæ¬¢ã€‚å–œæ¬¢çš„ç¨‹åº¦æœ‰åˆ°ä¼šç”¨â€œè¶…â€è¿™ç§å°‘ç”¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2ogozvsg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2pCB3svm">ä¹…ä¿å²ç»ªé‡Œ Nogifes 7å‘¨å¹´ç¬¬2å¼¾ã®ãƒ†ãƒ¼ãƒã¯ã€å¤©ä½¿ã¨å¦–ç²¾ğŸª½ã€è§†é¢‘ é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2pcb3svm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> Nogifes 7å‘¨å¹´ç¬¬2å¼¾ã®ãƒ†ãƒ¼ãƒã¯ã€å¤©ä½¿ã¨å¦–ç²¾ğŸª½ã€è§†é¢‘ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaim">https://h5.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2pCudnEf">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.11.28 19:10ã€Œå‘œå‘¼å‘¼ã€ä»Šå¤©æ˜¯æš´å‡»çš„å¤§ç»“å±€ã€‚å¤§ç»“å±€äº†å•Šï¼Œå¾ˆä¸èˆã€‚å¤ªä¸èˆäº†ã€‚ä½†æ˜¯å¸Œæœ›å¤§å®¶èƒ½è§‚èµã€‚æ„Ÿè§‰å¿ƒé‡ŒçœŸçš„è¦å˜å¾—ç©ºè½è½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2pcudnef/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2puZnFte">ä¹…ä¿å²ç»ªé‡Œ nogifes 7å‘¨å¹´ç¬¬2å¼¾ã®ãƒ†ãƒ¼ãƒã¯ã€å¤©ä½¿ã¨å¦–ç²¾ğŸª½ã€èƒŒæ™¯å›¾ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2puznfte/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> nogifes 7å‘¨å¹´ç¬¬2å¼¾ã®ãƒ†ãƒ¼ãƒã¯ã€å¤©ä½¿ã¨å¦–ç²¾ğŸª½ã€èƒŒæ™¯å›¾ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/lar">https://tvax1.sinaimg.cn/lar</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2qWZt35F">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä»Šæ™šæ˜¯å¤§ç»“å±€ã€‚åœ¨å¤§å®¶çš„é€‰æ‹©ä¹‹å‰ã€‚å¤§å®¶èƒ½å»çœ‹çš„è¯æˆ‘ä¼šå¾ˆå¼€å¿ƒçš„ã€‚ä»Šå¤©å‘çš„æ˜¯æ€é’é‚£å¤©çš„ç…§ç‰‡ã€‚å¾ˆæ™´æœ—ã€ç¾å¥½çš„ä¸€å¤©ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2qwzt35f/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigr &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2rIkgxPK">ä¹…ä¿å²ç»ªé‡Œ via.ä¹ƒæœ¨æ”ä¸åšä½œçš„ç¾ä¸½å’Œé€æ˜æ„Ÿï¼Œç¡®å®ç»™äººè¿™å°±æ˜¯ä¹ƒæœ¨å‚46ï¼çš„æ„Ÿè§‰å•Š by.æ¢…æ¾¤ç¾æ³¢ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2rikgxpk/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.ä¹ƒæœ¨æ”<!-- raw HTML omitted -->ä¸åšä½œçš„ç¾ä¸½å’Œé€æ˜æ„Ÿï¼Œç¡®å®ç»™äººè¿™å°±æ˜¯ä¹ƒæœ¨å‚46ï¼çš„æ„Ÿè§‰å•Š by.æ¢…æ¾¤ç¾æ³¢ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/11/28/1215540863/throughline-lord-of-misrule-throwback">The Lord Of Misrule (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-11-28-1215540863-throughline-lord-of-misrule-throwback/">
    
    
    
    
    
      
    
    By the time his book went to press in London, on November 18, 1633, Thomas Morton had been exiled from the Puritan colonies in Massachusetts. His crimes: drinking, carousing, and â€” crucially â€” building social and economic ties with Native people. His book outlined a vision for what America could become. A very different vision than that of the Puritans.<!-- raw HTML omitted --><!-- raw HTML omitted -->But the book wouldn&rsquo;t be published that day. It wouldn&rsquo;t be published for years. Because agents for the Puritan colonists stormed the press and destroyed every copy.<!-- raw HTML omitted --><!-- raw HTML omitted -->Today on the show, the story of what&rsquo;s widely considered &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://yufree.cn/cn/2024/11/28/f-water/">æ°Ÿæ°´éš¾æ”¶</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-28</span>
  </div>
  <div class="summary">
    <a href="/post/yufree-cn-cn-2024-11-28-f-water/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39597789/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Atrial Fibrillation in Patients with Very High Risk for Stroke and Adverse Events-Insights from the Observational ARENA Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39597789-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Atrial fibrillation (AF) is a major cause of stroke. An individual risk estimation remains challenging, as AF patients with and without cerebrovascular event (CVE) may differ in yet unknown factors beyond those covered by the CHA(2)DS(2)-VASc score. We aimed to identify differences between AF patients with and without CVE with regard to AF characteristics and treatment, vascular risk factors and comorbidities, prognosis and outcome. Methods: We analyzed patients included in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39598081/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Sex Differences in Long-Term Survival and Cancer Incidence After Ruptured Abdominal Aortic Aneurysm Repair</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39598081-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Long-term gender-specific survival and cancer incidence in patients with ruptured abdominal aortic aneurysm (rAAA) were investigated after endovascular (EVAR) and open repair (OAR). Methods: Data from 2933 patients (EVAR n = 1187, OAR n = 1746) from a health insurance company in Germany (men n = 2391, women n = 542) were analyzed. All patients were cancer-free in their history. Results: Perioperative mortality was significantly higher after OAR (42.6%) than after EVAR (21.2%; p &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39598116/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39598116-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Chronic obstructive pulmonary disease (COPD) is commonly associated with ageing, with the prevalence and severity increasing by age. Smoking-induced premature ageing is thought to contribute to COPD, particularly lung emphysema. This study aimed to explore the relationship between lung function impairment and skin texture, as a marker of biological or premature ageing, in COPD patients. Methods: A subcohort from the COSYCONET COPD-study was analyzed, where skin-relief replicas of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39599639/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Understanding the Food and Nutrition Insecurity Drivers in Some Emergency-Affected Countries in the Eastern Mediterranean Region from 2020 to 2024</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39599639-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This research seeks to enhance the understanding of the multifaceted drivers of food and nutrition insecurity in emergency-affected countries within the Eastern Mediterranean region and investigate the dynamics of food and nutrition security in countries facing emerging emergencies. This is a descriptive aim to determine the key factors and challenges affecting food security and nutrition status in ten countries in the Eastern Mediterranean region (Afghanistan, Djibouti, Iraq, Lebanon, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39599646/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Associations Between Dietary Patterns and Quality of Life in a Longitudinal Cohort of Colorectal Cancer Survivors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39599646-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among CRC survivors in the United States, the Western diet was concurrently associated with worse social functioning. Loss of appetite was reported by CRC survivors following both dietary patterns, suggesting that loss of appetite may be a global experience for CRC survivors during this timeframe. Further research is needed to understand specific social challenges experienced by CRC survivors and develop supportive care interventions to address appetite and nutritional &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39599703/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Assessment of the General Nutrition Knowledge of Students from the University of Novi Sad (Vojvodina, Serbia)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39599703-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Healthy nutrition is necessary for a good quality of life and reduction in the risk of developing diseases. Research indicates that students do not usually have healthy eating habits. Knowledge about nutrition, dietary guidelines, food groups and the nutrients they contain, the selection and adequate preparation of food, and the health consequences of unhealthy nutrition can influence the eating habits of students. Until recently, no research had been conducted on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39599722/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Vitamin D Is Associated with Lipid Metabolism: A Sex- and Age-Dependent Analysis of a Large Outpatient Cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39599722-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Vitamin D is a fat-soluble steroid that influences cardiovascular health by affecting lipid metabolism. Since dyslipidemia is a key risk factor for cardiovascular disease (CVD), our study aimed to explore the relationship between vitamin D levels and lipid parameters, considering the effects of age and gender. Methods: In this cross-sectional study of 47,778 outpatients, we analyzed correlations between two forms of vitamin D-25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39599982/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Nonsteroidal Anti-Inflammatory Drugs Decrease Coagulopathy Incidence in Severe Burn Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39599982-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The study investigated the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on burn-induced coagulopathy in severely burned patients. Patients with a greater than 20% TBSA were identified in the TriNetX research network and categorized into receiving or not receiving NSAIDs in the first week after the burn. The statistical significance of the rate of burn-induced coagulopathy, mortality and sepsis in the week following injury was analysed. We observed 837 severely burned patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39600048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">The availability of common patient-reported outcome measures in hand surgery across Europe</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39600048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Many European healthcare systems emphasize value-based care to improve outcomes and control costs. Assessing function and satisfaction in hand surgery relies on patient reported outcome measures. This study evaluates the use of these outcome measures across Europe, focusing on diversity and language validation.A comprehensive database search for hand-specific patient reported outcome measures assessed availability for all official languages in Europe focusing on transculturally adapted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39600188/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Prognosis of primary cutaneous angiosarcoma versus radiation-induced angiosarcoma: A cohort study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39600188-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39600602/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Ruminative thinking mediates the effects of exposure to adverse life events on psychotic-like experiences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39600602-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: A growing literature has shown that exposure to adverse life events during childhood or adolescence is associated with the presence of psychotic-like experiences (PLEs), which is in turn associated with the risk of psychotic outcomes. Ruminative thinking, i.e., the tendency to dwell on particular issues or ideas, may affect the perceived aversiveness and ability to cope with adverse life events. However, the role that rumination plays in the relationship between adverse life &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39601057/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Grover&#39;s disease-like patterns in early pityriasis rubra pilaris</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39601057-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39601137/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Bilateral hemorrhage of lower legs evolving into gangrene in a young woman with systemic symptoms</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39601137-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39601229/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">The sustainability impacts of a web-based outpatient booking application</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39601229-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The adoption of the web-based outpatient booking application led to a substantial reduction in carbon emissions and operating costs, alongside enhanced operational efficiency and productivity. These benefits are anticipated to be enduring, especially in the face of an ever-increasing demand for medical imaging &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39601370/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Sustained Complete Remission in SÃ©zary Syndrome using Extracorporeal Photopheresis: A Multicentric Case Series</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39601370-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39601382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Endoscopic retrograde cholangiopancreatography training conditions, results from a pan-European survey: Between vision and reality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39601382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The first pan-European survey investigating ERCP training conditions reveals strong support for structured training and the concentration of training efforts within centers meeting specific quality metrics. Furthermore, this survey exposes the low availability of structured training programs with many trainees practicing at lower-volume centers and 71% of all trainees having little hands-on exposure. These data should motivate to standardize ERCP training conditions further &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39601754/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Exploring the dynamics of messenger ribonucleoprotein-mediated translation repression</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39601754-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Translational control is crucial for well-balanced cellular function and viability of organisms. Different mechanisms have evolved to up- and down-regulate protein synthesis, including 3' untranslated region (UTR)-mediated translation repression. RNA binding proteins or microRNAs interact with regulatory sequence elements located in the 3' UTR and interfere most often with the rate-limiting initiation step of translation. Dysregulation of post-transcriptional gene expression leads to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602139/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602139-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, nemolizumab monotherapy led to clinically meaningful and statistically significant improvements in core signs and symptoms of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602147/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602147-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION AND RELEVANCE: These findings provide evidence for shared decision-making between patients and physicians to consider extending the rescreening intervals after an NCS result beyond the currently recommended 10 years, particularly for individuals with a low-risk profile. These results showed, as a proof of concepts, the importance of considering known CRC risk factors when making decisions for colonoscopy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602216/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241127173247&amp;v=2.18.0.post9&#43;e462414">The Views and Experiences of Integrated Care System Commissioners About the Adoption and Implementation of Virtual Wards in England: Qualitative Exploration Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602216-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241127173247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: VWs have the potential to reform patient-centered care in England and were considered a promising approach by commissioners in this study. However, there should be greater clarity over definitions and specifications for technology enablement and evidence provided about how technology can enhance patient care. The use of less hospital-centric language, a greater focus on patient-centered measures of success, and more time allowance to ensure the development of technology-enabled &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602634/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Immunotherapy for Early-Stage Triple-Negative Breast Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602634-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602635/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Reducing the Cost of Saving Children&#39;s Lives</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602635-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602636/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Building Bone while Making Milk</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602636-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602637/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">A Diagnostic Sequence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602637-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Doxorubicin-Trabectedin in Leiomyosarcoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602638-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602639/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Doxorubicin-Trabectedin in Leiomyosarcoma. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602639-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602640/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Azithromycin to Reduce Mortality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602640-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602641/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Azithromycin to Reduce Mortality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602641-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602642/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Azithromycin to Reduce Mortality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602642-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Azithromycin to Reduce Mortality. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602644/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602644-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602645/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602645-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602646/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Pancreatic Cysts</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602646-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602647/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Pancreatic Cysts. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602647-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39602653/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241128174911&amp;v=2.18.0.post9&#43;e462414">Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39602653-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241128174911-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Obe-cel resulted in a high incidence of durable response among adults with relapsed or refractory B-cell ALL, with a low incidence of grade 3 or higher immune-related toxic effects. (Funded by Autolus Therapeutics); FELIX ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2dgxnVxm">å…¨çƒæœ€æ–°HIVæ„ŸæŸ“æµè¡Œç—…æ•°æ®æ­æ™“ã€‚ä¸–ç•Œè‰¾æ»‹ç—…æ—¥æ˜¯ä¼—å¤šæ‚å¿—å‘è¡¨HIVç ”ç©¶çš„æ—¶æœŸã€‚ä»Šå¤©ä¸Šçº¿çš„Lancet HIVå‘è¡¨äº†ä¸€é¡¹æ¥è‡ªäºæ–°å† ç–«æƒ…ä¸­åšå‡ºé‡å¤§è´¡çŒ®çš„IHMEå’Œåç››é¡¿å¤§å­¦ç ”...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2dgxnvxm/">
    
    
    
    
    
      
    
    å…¨çƒæœ€æ–°HIVæ„ŸæŸ“æµè¡Œç—…æ•°æ®æ­æ™“ã€‚ä¸–ç•Œè‰¾æ»‹ç—…æ—¥æ˜¯ä¼—å¤šæ‚å¿—å‘è¡¨HIVç ”ç©¶çš„æ—¶æœŸã€‚ä»Šå¤©ä¸Šçº¿çš„Lancet HIVå‘è¡¨äº†ä¸€é¡¹æ¥è‡ªäºæ–°å† ç–«æƒ…ä¸­åšå‡ºé‡å¤§è´¡çŒ®çš„IHMEå’Œåç››é¡¿å¤§å­¦ç ”ç©¶è®ºæ–‡ï¼ŒæŠ¥é“äº†å…¨çƒHIVæµè¡Œçš„å…³é”®æ•°æ®ã€‚ç ”ç©¶å‘ç°ï¼Œå…¨çƒæ¯å¹´HIVæ–°å‘æ„ŸæŸ“ç‡æ˜¾è‘—ä¸‹é™ï¼Œä»2010å¹´211ä¸‡ä¾‹/å¹´ï¼Œä¸‹é™åˆ°äº†2021å¹´165ä¸‡ä¾‹/å¹´ï¼Œä¸‹é™22%ã€‚HIVç›¸å…³æ­»äº¡ä»2010å¹´çš„119ä¸‡/å¹´ï¼Œä¸‹é™åˆ°äº†2021å¹´çš„71.8ä¸‡ï¼Œä¸‹é™äº†39.7%ã€‚è¿™ä¸€ä¸‹é™ä¸»è¦æ˜¯éæ´²ï¼ˆæ’’å“ˆæ‹‰ä»¥å—ï¼‰å’Œå—äºšä¸‹é™å¸¦åŠ¨çš„ã€‚ä½†æ˜¯ï¼Œä¿„ç½—æ–¯ã€ä¸œæ¬§ã€ä¸­äºšåŠåŒ—éå‡å‡ºç°äº†HIVæ„ŸæŸ“å’Œæ­»äº¡æ˜¾è‘—å¢åŠ çš„æƒ…å†µã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç›®å‰å…¨çƒå…±æœ‰HIVæ„ŸæŸ“è€…ï¼ˆPWHï¼‰4000ä¸‡ï¼ˆ2010å¹´ä¸º2900ä¸‡ï¼‰ã€‚ç ”ç©¶æŒ‡å‡ºï¼Œåœ¨æ’’å“ˆæ‹‰ä»¥å—åœ°åŒºï¼Œ1995å¹´æ¯äººä¸€ç”Ÿä¸­æ„ŸæŸ“HIVçš„å‡ ç‡ä¸º21.8%ï¼Œ2021å¹´ä¸‹é™åˆ°äº†8.7%ï¼Œå…¨çƒç–¾ç—…è´Ÿæ‹…åˆ†ææ˜¾ç¤ºå¤§éƒ¨åˆ†äººåœ°åŒºäººå£ä¸€ç”Ÿæ„ŸæŸ“HIVå‡ ç‡å°äº1%ã€‚ä½†æ˜¯å› ä¸ºæ„ŸæŸ“åŸºæ•°å¤§ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2dtpeOrf">ä¸Šå‘¨è¯´NIHä¸»ä»»æ˜¯ç›®å‰å”¯ç‹¬æ²¡æœ‰è¢«æåçš„ï¼ˆç½‘é¡µé“¾æ¥ï¼‰ã€‚Trumpåˆšå®£å¸ƒå°†æåæ–¯å¦ç¦å¤§å­¦å°åº¦è£”æ•™æˆJay Bhattacharyaä¸ºNIHä¸»ä»»ã€‚è¿™æ˜¯å¾ˆå¤šåª’ä½“é¢„æµ‹çš„ã€‚Bhattacharyaæ˜¯å«...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2dtpeorf/">
    
    
    
    
    
      
    
    ä¸Šå‘¨è¯´NIHä¸»ä»»æ˜¯ç›®å‰å”¯ç‹¬æ²¡æœ‰è¢«æåçš„ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ã€‚Trumpåˆšå®£å¸ƒå°†æåæ–¯å¦ç¦å¤§å­¦å°åº¦è£”æ•™æˆJay Bhattacharyaä¸ºNIHä¸»ä»»ã€‚è¿™æ˜¯å¾ˆå¤šåª’ä½“é¢„æµ‹çš„ã€‚Bhattacharyaæ˜¯å«ç”Ÿç»æµå­¦æ•™æˆï¼Œä»–åœ¨æ–°å† ç–«æƒ…ä¸­å› ä¸ºåšå†³åå¯¹lockdownï¼ˆå…³é—­å…¬å…±åœºæ‰€ï¼‰å’Œå£ç½©ä»¤èµ°çº¢ã€‚ä»–åœ¨ç–«æƒ…åˆæœŸè¯¸å¤šåª’ä½“ä¸Šå®£ä¼ herd immunityã€‚ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/4a994b1">https://tvax3.sinaimg.cn/large/4a994b1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2ewf6ctt">ç‰¹åˆ«æ¨èä¼ æŸ“ç—…ã€ç—…æ¯’å­¦ã€å…ç–«å­¦å’Œè‡ªèº«å…ç–«ç—…åŒè¡Œçœ‹çœ‹æ˜¨å¤©æˆ‘æ¨èçš„NIHè§†é¢‘ï¼ˆå¯ä»¥çœ‹å‰20åˆ†é’Ÿï¼›ç½‘é¡µé“¾æ¥ï¼‰ï¼Œè¿™å¯¹åœ¨ç¾ç›¸å…³é¢†åŸŸä»ä¸šäººå‘˜ï¼ˆä»PhDå­¦ç”Ÿåˆ°postdocå’ŒMD fe...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2ewf6ctt/">
    
    
    
    
    
      
    
    ç‰¹åˆ«æ¨èä¼ æŸ“ç—…ã€ç—…æ¯’å­¦ã€å…ç–«å­¦å’Œè‡ªèº«å…ç–«ç—…åŒè¡Œçœ‹çœ‹æ˜¨å¤©æˆ‘æ¨èçš„NIHè§†é¢‘ï¼ˆå¯ä»¥çœ‹å‰20åˆ†é’Ÿï¼›<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼Œè¿™å¯¹åœ¨ç¾ç›¸å…³é¢†åŸŸä»ä¸šäººå‘˜ï¼ˆä»PhDå­¦ç”Ÿåˆ°postdocå’ŒMD fellowåˆ°ç”³è¯·NIAIDç»è´¹çš„æ•™æˆï¼‰éƒ½ä¼šæœ‰æ‰€è£¨ç›Šã€‚è™½ç„¶è¿™æ˜¯HIVæ²»æ„ˆçš„ä¼šè®®ï¼Œä½†æ˜¯å»å¹´ä¸Šä»»çš„NIAIDä¸»ä»»Jea &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2f5Z7DWK">Redditä¸Šæœ‰äººå‘äº†ä¸€ä¸ªæ‰€æœ‰å¤§è¯å‚ç‹ç‰Œè¯ç‰©ï¼ˆblockbusterï¼‰ä¸“åˆ©è¿‡æœŸæ—¶é—´ï¼ˆpatent cliffï¼‰ã€‚è¿™äº›è¯ç‰©å¾ˆå¤šéƒ½æ˜¯è€³ç†Ÿèƒ½è¯¦çš„ï¼ŒæŒ‰ç…§2023å¹´é”€å”®é¢ï¼Œæœ€é‡è¦çš„æ— ç–‘æ˜¯Merckçš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2f5z7dwk/">
    
    
    
    
    
      
    
    Redditä¸Šæœ‰äººå‘äº†ä¸€ä¸ªæ‰€æœ‰å¤§è¯å‚ç‹ç‰Œè¯ç‰©ï¼ˆblockbusterï¼‰ä¸“åˆ©è¿‡æœŸæ—¶é—´ï¼ˆpatent cliffï¼‰ã€‚è¿™äº›è¯ç‰©å¾ˆå¤šéƒ½æ˜¯è€³ç†Ÿèƒ½è¯¦çš„ï¼ŒæŒ‰ç…§2023å¹´é”€å”®é¢ï¼Œæœ€é‡è¦çš„æ— ç–‘æ˜¯Merckçš„Keytrudaï¼ˆanti-PD-1ï¼‰ï¼Œ2028å¹´è¿‡ä¸“åˆ©æœŸï¼ˆåŒå¹´HPVç–«è‹—GARDASIL 9ä¹Ÿå°†è¿‡ä¸“åˆ©æœŸï¼‰ï¼Œ2023å¹´é”€å”®é¢250äº¿ç¾å…ƒã€‚ç„¶åæ˜¯Novo Nordiskçš„Ozempicï¼ˆGLP-1Raï¼‰ï¼Œ2032å¹´è¿‡ä¸“åˆ©æœŸï¼Œ2023å¹´184äº¿ç¾å…ƒã€‚ä¹‹åæ˜¯BMSå’ŒPfizerçš„Eliquisï¼ˆXa-iï¼‰ï¼Œ2026å¹´è¿‡ä¸“åˆ©æœŸï¼Œ2023å¹´é”€å”®é¢122äº¿ã€‚<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P2kQkAaiG">æˆ‘ä»¬çš„6ä¸ªæœˆæ³¨å°„ä¸€æ¬¡çš„LEN HIV PrEPç ”ç©¶PURPOSE 2åœ¨NEJMä¸Šçº¿äº†ã€‚</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p2kqkaaig/">
    
    
    
    
    
      
    
    æˆ‘ä»¬çš„6ä¸ªæœˆæ³¨å°„ä¸€æ¬¡çš„LEN HIV PrEPç ”ç©¶PURPOSE 2åœ¨NEJMä¸Šçº¿äº†ã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/P2dF35TFe">å¹´åº•è§£çƒ¦ï¼ã€Šå¤ªç™½é‡‘æ˜Ÿæœ‰ç‚¹çƒ¦ã€‹å³å°†ç”±@åˆ˜å¤©æ± __ æ”¹ç¼–ä¸ºèˆå°å‰§ï¼Œæ˜å¹´1æœˆ15-18æ—¥å³å°†åœ¨ä¸Šæµ·å¤§å‰§é™¢å¼€æ¼”ï¼Œå¸Œæœ›å¤§å®¶èµ°è¿›å‰§åœºï¼Œè®©æˆå‰§è§£å¼€çƒ¦äººçƒ¦äº‹ï¼#èˆå°å‰§å¤ªç™½é‡‘æ˜Ÿæœ‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-p2df35tfe/">
    
    
    
    
    
      
    
    å¹´åº•è§£çƒ¦ï¼ã€Šå¤ªç™½é‡‘æ˜Ÿæœ‰ç‚¹çƒ¦ã€‹å³å°†ç”±<!-- raw HTML omitted -->@åˆ˜å¤©æ± __<!-- raw HTML omitted --> æ”¹ç¼–ä¸ºèˆå°å‰§ï¼Œæ˜å¹´1æœˆ15-18æ—¥å³å°†åœ¨ä¸Šæµ·å¤§å‰§é™¢å¼€æ¼”ï¼Œå¸Œæœ›å¤§å®¶èµ°è¿›å‰§åœºï¼Œè®©æˆå‰§è§£å¼€çƒ¦äººçƒ¦äº‹ï¼<!-- raw HTML omitted --><!-- raw HTML omitted -->#èˆå°å‰§å¤ªç™½é‡‘æ˜Ÿæœ‰ç‚¹çƒ¦#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a href=&ldquo;<a href="https://weibo.com/7964576517%22">https://weibo.com/7964576517&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P2fDWnJdP">ç°åœºè§ - è½¬å‘ @æ‰¾å€Ÿå£å®‰é™:&amp;ensp;æ—¥æœ¬æ£‹æ‰‹å¦‚æœè¿›å†³èµ›çš„è¯æˆ‘å€’æ˜¯æƒ³å»ç°åœºçš„å›¾ç‰‡ï¼šè°¢ä¾æ—»#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p2fdwnjdp/">
    
    
    
    
    
      
    
    ç°åœºè§<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ‰¾å€Ÿå£å®‰é™<!-- raw HTML omitted -->:â€‚æ—¥æœ¬æ£‹æ‰‹å¦‚æœè¿›å†³èµ›çš„è¯æˆ‘å€’æ˜¯æƒ³å»ç°åœºçš„<!-- raw HTML omitted --><!-- raw HTML omitted -->å›¾ç‰‡ï¼šè°¢ä¾æ—»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_sup">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_sup</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2iuLqK81">ä¹…ä¿å²ç»ªé‡Œ via ä¹ƒæœ¨å‚46ANN Xä¹ƒæœ¨å‚46ANNçº¿ä¸‹æ´»åŠ¨é’æ˜¥æ–‡åŒ–èŠ‚ç›¸å…³å‘¨è¾¹ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2iulqk81/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->via ä¹ƒæœ¨å‚46ANN X<!-- raw HTML omitted -->ä¹ƒæœ¨å‚46ANNçº¿ä¸‹æ´»åŠ¨é’æ˜¥æ–‡åŒ–èŠ‚ç›¸å…³å‘¨è¾¹ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/">https://tvax4.sinaimg.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2jgPqL76">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# åªå‰©ä¸‹ä¸¤é›†äº†ã€‚...å¯æ˜¯æœªæ¥ä¼šå˜æˆä»€ä¹ˆæ ·å‘¢ï¼ï¼Ÿä»Šæ™šä¹Ÿä¸€å®šè¦çœ‹å“¦ã€‚å“å‘€å•Šå•Šå•Šã€‚ã€‚å¥½å¯‚å¯ã€‚ã€‚ç¬¬ä¸€å¤©çš„å‡›é…±ã€‚éå¸¸ç´§å¼ çš„è¡¨æƒ…ã€‚æ‹æ‘„ç°åœºæ¯å¤©...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2jgpql76/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P2jpWrOyI">ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p2jpwroyi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann&amp;nogizaka46 X <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1">https://tvax2.sinaimg.cn/large/006z6nxLgy1</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

